Use of osteobiologics in the management of osteoporotic fractures.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21566475.
- Also identified by DOI 10.1097/BOT.0b013e31821b8c52.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Osteoporotic fractures present a number of significant challenges for surgical management, including high degrees of fracture comminution, poor implant fixation secondary to inferior bone quality, and compromised capacity for fracture healing. Osteobiologics are materials/agents that can promote fracture healing and enhance fracture stability. Given the challenges presented by osteoporotic fractures, they seem ideally suited to potentially benefit from the application of osteobiologics. Despite this, limited clinical investigation into the use of osteobiologics in the management of osteoporotic fractures has been performed. This article reviews a select number of osteobiologic products and the evidence for their use in osteoporotic fractures.
Medical subject headings
- Biocompatible Materials
- Bone Density Conservation Agents
- Bone Transplantation
- Diphosphonates
- Fractures, Spontaneous
- Osteoporosis